Handover of the extension notice to the DigiMed Bayern flagship project. f.l.t.r.: Verena Heidel (Project Manager, Deutsches Herzzentrum München), Dr. med. Veronika Sanin (Vroni study management, Deutsches Herzzentrum München) , Prof. Dr. Dieter Kranzmüller (Chairman of the Board of Directors Leibniz-Rechenzentrums), Dr. Jens Wiehler (Managing Director, DigiMed Bayern), Dr. med. Fabian Starnecker (Project Leader, HerzFit-App, Deutsches Herzzentrum München), Prof. Dr. med. Heribert Schunkert (Medical Director, Deutsches Herzzentrum München & Scientific Director, DigiMed Bayern), Prof. Dr. Horst Domdey (Managing Director BioM Biotech Cluster Development GmbH), Klaus Holetschek (Minister of State for Health and Care, StMGP), Dr. Jörg Traub (Project Manager Technologie & Director Gesundheit, Bayern Innovativ GmbH), Prof. Dr. Annette Peters (Director Institute of Epidemiology, Helmholtz Munich), Tina Engelhardt (Financial processing I Project Management Bavaria, Bayern Innovativ GmbH). © BioM

Digitisation of medicine is advancing: Holetschek extends flagship project "DigiMed Bayern - for the medicine of the future"

Martinsried, 12 September 2022 - The flagship project "DigiMed Bayern - for the medicine of the future" is being extended by one year. Bavaria's Minister of Health, Klaus Holetschek, personally handed over the extension notice to the managing BioM Biotech Cluster Development GmbH last Friday in the presence of top-class DigiMed Bayern partners from science and hospitals. DigiMed Bayern aims to prevent heart attacks and strokes and stands for data-based personalised medicine - using the widespread disease of atherosclerosis as an example.

The pandemic has shown how important science is in fighting crises. People with cardiovascular diseases have suffered particularly from COVID-19. In Bavaria alone, about 50,000 people died of cardiovascular diseases in 2020, about 6,500 from heart attacks, according to the Bavarian Heart Report. Prevention is the best protection: both to avoid the viral infection and to survive it in good health.

Please find the complete press release here.

 

DigiMed Bayern for the Medicine of the Future

 

P4 medicine (predictive, preventive, personalized, participatory) is one of the world's most promising developments for improved, holistic and efficient healthcare.
DigiMed Bayern's goal is to guide Bavaria with a flagship project into this medicine of the future.

The flagship P4-medicine project DigiMed Bayern was launched at the end of 2018 with more than € 20 million funding by the Bavarian State Ministry of Health and Care. DigiMed Bayern combines comprehensive datasets of patients diagnosed with atherosclerotic diseases, such as coronary heart disease and stroke, or with genetic risk factors. This dataset will be further enriched with state-of-the-art multi-dimensional molecular characterization (-omics technologies) of associated sample material. For the integrative analysis of the resulting "Big Data", an ethically and legally compliant, highly secure and sustainable IT infrastructure will be fundamentally designed and implemented. Finally, patients and persons at risk will benefit from advancements in disease risk prediction, targeted prevention, diagnosis and treatment.

funded by


Scientific Management


Executive Management